These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6122332)

  • 1. The mode of antiarrhythmic action of melperone.
    Platou ES; Refsum H; Myhre ES; Amlie JP; Landmark K
    Acta Pharmacol Toxicol (Copenh); 1982 Feb; 50(2):108-12. PubMed ID: 6122332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrophysiological effects of melperone in the dog heart in situ - a new antiarrhythmic drug.
    Refsum H; Amlie JP; Platou ES; Owren T; Landmark K
    Cardiovasc Res; 1981 Mar; 15(3):131-6. PubMed ID: 6114796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of beta-adrenergic and cholinergic blockade on the electrophysiological effects of melperone in the dog heart in situ.
    Platou ES; Refsum H; Amlie JP; Landmark K
    Cardiovasc Res; 1981 Mar; 15(3):137-43. PubMed ID: 6114797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma levels and cardiac electrophysiological effects of melperone in the dog.
    Platou ES; Refsum H; Amlie JP; Landmark K
    Eur J Pharmacol; 1982 Aug; 82(1-2):1-7. PubMed ID: 7128676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-adrenoceptor blockade and class III antiarrhythmic activity combined: hemodynamic and electrophysiological effects of melperone in the dog.
    Platou ES; Myhre ES; Refsum H
    Can J Physiol Pharmacol; 1986 Oct; 64(10):1286-90. PubMed ID: 2879618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrophysiological effects of melperone on isolated rabbit heart muscles.
    Ikeguchi S; Hashimoto S; Horie M; Kadoya M; Konishi T; Kawai C
    Br J Pharmacol; 1988 Aug; 94(4):1063-8. PubMed ID: 3207973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrophysiological effects of Org 7797 in the closed-chest anaesthetized dog.
    Leboeuf J; Basiez M; Massingham R
    Br J Pharmacol; 1993 Sep; 110(1):23-8. PubMed ID: 8220882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Class III antiarrhythmic action linked with positive inotropy: antiarrhythmic, electrophysiological, and hemodynamic effects of the sea-anemone polypeptide ATX II in the dog heart in situ.
    Platou ES; Refsum H; Hotvedt R
    J Cardiovasc Pharmacol; 1986; 8(3):459-65. PubMed ID: 2425158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological mapping of regional effects in the rabbit heart of some new antiarrhythmic drugs.
    Millar JS; Vaughan Williams EM
    Br J Pharmacol; 1983 Jul; 79(3):701-9. PubMed ID: 6652350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasodilator and inotropic effects of the antiarrhythmic drug melperone.
    Platou ES; Smiseth OA; Refsum H; Rouleau JL; Chuck LH
    J Cardiovasc Pharmacol; 1982; 4(4):645-51. PubMed ID: 6181340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Class III antiarrhythmic action in experimental atrial fibrillation and flutter in dogs.
    Platou ES; Refsum H
    J Cardiovasc Pharmacol; 1982; 4(5):839-46. PubMed ID: 6182417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ventricular and atrial electrophysiological effects of a IC antiarrhythmic drug, cibenzoline, in the innervated dog heart. Role of sodium and calcium channels.
    Timour Q; Aupetit JF; Loufoua-Moundanga J; Bertrix L; Freysz M; Faucon G
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Sep; 340(3):338-44. PubMed ID: 2554155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential actions on rabbit nodal, atrial, Purkinje cell and ventricular potentials of melperone, a bradycardic agent delaying repolarization: effects of hypoxia.
    Millar JS; Vaughan Williams EM
    Br J Pharmacol; 1982 Jan; 75(1):109-21. PubMed ID: 7074278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemodynamic and metabolic effects of the antiarrhythmic drug melperone during acute left ventricular failure in dogs.
    Smiseth OA; Platou ES; Refsum H; Mjøs OD
    Cardiovasc Res; 1981 Dec; 15(12):724-30. PubMed ID: 7326689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of electrophysiologic mechanisms for the antiarrhythmic actions of R 56865 in cardiac glycoside toxicity.
    Damiano BP; Stump GL; Yagel SK
    J Cardiovasc Pharmacol; 1991 Sep; 18(3):415-28. PubMed ID: 1720842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the electrophysiological effects of two neuroleptics, melperone and thioridazine, on isolated rat atria.
    Refsum H; Passwal M; Olsson SO
    Eur J Pharmacol; 1978 Jun; 49(3):285-93. PubMed ID: 658142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrophysiologic properties of UK-66,914, a novel class III antiarrhythmic agent.
    Gwilt M; Dalrymple HW; Burges RA; Blackburn KJ; Dickinson RP; Cross PE; Higgins AJ
    J Cardiovasc Pharmacol; 1991 Mar; 17(3):376-85. PubMed ID: 1711597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrophysiological effects of penticainide in the anaesthetized dog.
    Sassine A; Brugada J; Munoz A; Romero-Ayala L; Masse C
    Drugs Exp Clin Res; 1987; 13(1):15-20. PubMed ID: 3595440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigations to characterize a new antiarrhythmic drug bisaramil.
    Paroczai M; Karpati E
    Pharmacol Res; 1991 Aug; 24(2):149-62. PubMed ID: 1684242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasoactive intestinal polypeptide facilitates atrioventricular nodal conduction and shortens atrial and ventricular refractory periods in conscious and anesthetized dogs.
    Rigel DF; Lathrop DA
    Circ Res; 1990 Dec; 67(6):1323-33. PubMed ID: 2245498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.